About the study

The purpose of this study is to describe the safety and efficacy of opicapone plus standard of care in elderly patients with PD in the real-world setting

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria

1. Patient or legally acceptable representative willing and able to provide informed consent as mandated by local regulation
2. Patient with clinical diagnosis of idiopathic PD (excluding non-idiopathic PD: atypical Parkinsonism, secondary [acquired or symptomatic] Parkinsonism, Parkinson-plus syndrome)
3. Patient with age >=75 years at enrolment
4. Patient with end-of-dose motor fluctuations suitable for additional treatment optimization

Exclusion criteria

1. Patient concurrently participating in any clinical trial
2. Patient who used tolcapone or opicapone previously
3. For the patient who starts opicapone: concomitant treatment with entacapone or tolcapone is not allowed
4. Patient with any contraindications to Ongentys use
5. Patient with any concomitant medical condition that could interfere with study assessments

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.